NIOX Group Plc (LON:NIOX – Get Free Report)’s share price fell 0.9% during trading on Friday . The stock traded as low as GBX 63.20 ($0.80) and last traded at GBX 63.60 ($0.80). 65,649 shares traded hands during mid-day trading, a decline of 93% from the average session volume of 985,164 shares. The stock had previously closed at GBX 64.20 ($0.81).
NIOX Group Trading Down 0.9 %
The business has a fifty day simple moving average of GBX 65.59 and a 200 day simple moving average of GBX 67.17. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.94 and a current ratio of 6.32. The stock has a market capitalization of £269.75 million, a price-to-earnings ratio of 3,180.00 and a beta of 0.92.
Insider Buying and Selling at NIOX Group
In other NIOX Group news, insider Garry Watts sold 27,109 shares of the business’s stock in a transaction on Friday, October 25th. The shares were sold at an average price of GBX 80 ($1.01), for a total transaction of £21,687.20 ($27,331.06). Company insiders own 46.72% of the company’s stock.
NIOX Group Company Profile
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
Featured Articles
- Five stocks we like better than NIOX Group
- How to Invest in the Best Canadian Stocks
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- How to Calculate Return on Investment (ROI)
- Top-Performing Non-Leveraged ETFs This Year
- What Are Dividend Achievers? An Introduction
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for NIOX Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIOX Group and related companies with MarketBeat.com's FREE daily email newsletter.